文献速递神经肿瘤小儿神经外科与脑积水

颅脊髓照射治疗转移性儿童低级别胶质瘤

Craniospinal irradiation for treatment of metastatic pediatric low-grade glioma.
PubMed 文献 · J Neurooncol · 2017-06-17

本研究回顾性分析单中心12例接受颅脊髓照射的转移性儿童低级别胶质瘤患者,5年无事件生存率和总生存率分别为71%和70%,未观察到3级及以上急性毒性。作者认为颅脊髓照射可考虑用于转移性儿童低级别胶质瘤,尤其是化疗后进展的年长儿童。

要点

  • 12例转移性儿童低级别胶质瘤患者接受颅脊髓照射,5年无事件生存率71%,总生存率70%。
  • 放疗前接受次全切除的患者无死亡,而活检后3例死亡(总生存log-rank P=0.01)。
  • 无患者发生3级及以上急性毒性。

核心结论

  • 接受颅脊髓照射的转移性儿童低级别胶质瘤患者无事件生存期长于仅化疗的历史队列,总生存期相似。
  • 作者认为颅脊髓照射可考虑用于转移性儿童低级别胶质瘤,尤其是化疗后进展的年长儿童。

研究设计与样本

  • 回顾性研究,纳入单中心所有接受颅脊髓照射的转移性儿童低级别胶质瘤患者,共12例,均经组织学确诊。
  • 无事件生存期定义为无疾病进展或继发性高级别胶质瘤的生存,日期从放疗第一天起算。

主要发现

  • 12例中9例初诊时即为转移性疾病,颅脊髓照射时中位年龄9.3岁。
  • 5年无事件生存率为71%(95%CI 33.7-89.5),5年总生存率为70%(95%CI 32.9-89.2)。
  • 放疗前接受次全切除的患者无死亡,而活检后3例死亡(总生存log-rank P=0.01)。
  • 放疗前接受次全切除的患者无事件生存期可能更长(无事件生存log-rank P=0.03),活检相对于次全切除的风险比为8.4(95%CI 0.8-84.0,P=0.07)。
  • 无患者发生3级及以上急性毒性。

临床怎么用

  • 作者认为颅脊髓照射可考虑用于转移性儿童低级别胶质瘤的管理,尤其是化疗后进展的年长儿童。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patients with disseminated pediatric low-grade glioma (LGG) initially treated with chemotherapy frequently experience disease progression, with 5-year event-free survival (EFS) of <20% and 10-year overall survival (OS) of approximately 70%. This study aimed to describe outcomes of metastatic pediatric LGG treated with craniospinal irradiation (CSI). A retrospective study was performed of all patients with metastatic pediatric LGG treated with CSI at a single institution. EFS was defined as survival without disease progression or secondary high-grade glioma. Dates were counted from the first day of irradiation. We identified 12 eligible patients; all had histologically confirmed LGG. Metastatic disease was present at initial presentation in 9 patients. The median age at CSI was 9.3 years. The 5-year EFS and OS were 71% (95% CI 33.7-89.5) and 70% (95% CI 32.9-89.2), respectively. No deaths were observed among the patients who underwent subtotal resection (STR) before radiotherapy, whereas 3 patients who had undergone biopsy died (OS log-rank P = 0.01). EFS may be longer among patients who underwent STR before RT (EFS log-rank P = 0.03), with a hazard ratio for biopsy of 8.4 (vs. STR; 95% CI 0.8-84.0, P = 0.07). No patient experienced acute toxicity of grade 3 or higher. Patients with metastatic pediatric LGG treated with CSI experienced longer EFS than historical cohorts treated with chemotherapy alone, with similar OS. CSI may be considered in the management of metastatic pediatric LGG, particularly in older children experiencing progression after chemotherapy.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Tsang DS, Murphy ES, Ezell SE, et al. Craniospinal irradiation for treatment of metastatic pediatric low-grade glioma. J Neurooncol. 2017. PMID: 28623604. doi:10.1007/s11060-017-2525-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。